The objective of this study by Jennifer Ammerman, Chaoyang Huang, Daniel Wright at MPI Research was to validate a bioanalytical method for the quantitation of potassium in human urine samples obtained from clinical studies; with patients dosed with potassium chloride in support of required bioequivalence studies.
Personalised medicine is not yet fully implemented in healthcare developments and the reasons might be scientific, technological, financial, regulatory or ethical. Thibault Helleputte at DNAlytics outlines recent trends regarding them and discusses the observation that relates to data science – or the lack of it – in current practice.
Vikki Brandi at Quintiles discusses key methodological, practical and ethical issues in the conduct of CF clinical trials with a focus on site identification, feasibility and clinical research studies.
Dr. Ian Kovacs of PAREXEL International explains why ccompanies need to consider integrated approaches to risk management, ensuring that such activities commence early in clinical development.